SCHEMBL12006

SCHEMBL12006

Cc1cccc(OC(C)C)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.59
ACHE P22303 2/20 0.58
RXRA P19793 1/20 0.47
RXRB P28702 1/20 0.47
ALDH1A1 P00352 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.45
GAA P10253 2/20 0.45
MEN1 O00255 1/20 0.45
HTT P42858 1/20 0.45
KMT2A Q03164 1/20 0.45
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
MAPT P10636 2/20 0.44
ADRB2 P07550 1/20 0.44
ADRB1 P08588 1/20 0.44
TP53 P04637 1/20 0.43
GABRA1 P14867 1/20 0.42
GABRG2 P18507 1/20 0.42
GABRB3 P28472 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL27571347 0.98 LMNA (0.57) LMNAACHERXRARXRBALDH1A1
SCHEMBL27512374 0.92 LMNA (0.56) LMNAACHERXRARXRBALDH1A1
SCHEMBL27469399 0.89 LMNA (0.53) LMNAACHERXRARXRBSMN1; SMN2
SCHEMBL18210776 0.88 RXRA (0.58) LMNAACHERXRARXRBGABRA1
SCHEMBL542640 0.86 ACHE (0.58) LMNAACHEALDH1A1SMN1; SMN2GAA
SCHEMBL4668319 0.86 LMNA (0.54) LMNAACHERXRARXRBSMN1; SMN2
SCHEMBL2968363 0.85 RXRA (0.53) LMNARXRARXRBALDH1A1SMN1; SMN2
SCHEMBL23467899 0.83 ACHE (0.54) LMNAACHEALDH1A1SMN1; SMN2GAA
SCHEMBL15146352 0.83 ACHE (0.54) LMNAACHEALDH1A1SMN1; SMN2GAA
SCHEMBL30333407 0.83 LMNA (0.55) LMNAACHEALDH1A1SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 410 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106967076-A One kind has 6H dibenzopyrans structural compounds and preparation method thereof 河南师范大学 2017-07-21 CN claimed
WO-2007069986-A1 NEW OXABISPIDINE COMPOUNDS FOR THE TREATMENT OF CARDIAC ARRHYTHMIAS ASTRAZENECA AB (SE) 2007-06-21 WO claimed
JP-60139636-A None JP disclosed
JP-62012732-A None JP disclosed
EP-4613784-A1 ESTER COMPOUND-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, (METH)ACRYLIC POLYMER, AND METHOD FOR PRODUCING SAME Mitsubishi Chemical Corporation (JP) 2025-09-10 EP disclosed
US-20250250223-A1 ESTER COMPOUND-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, (METH)ACRYLIC POLYMER, AND METHOD FOR PRODUCING SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2025-08-07 US disclosed
US-20250250370-A1 METHACRYLATE-CONTAINING COMPOSITION, METHOD FOR PRODUCING METHACRYLIC ESTER, POLYMERIZABLE COMPOSITION, AND METHOD FOR PRODUCING METHACRYLIC ACID POLYMER MITSUBISHI CHEMICAL CORPORATION (JP) 2025-08-07 US disclosed
CN-119923418-A Methacrylic acid-containing composition, method for producing methacrylic acid ester, polymerizable composition, and method for producing methacrylic acid polymer 三菱化学株式会社 2025-05-02 CN disclosed
CN-119562975-A Composition containing ester compound and method for producing same, polymerizable composition, (meth) acrylic polymer, and method for producing same 三菱化学株式会社 2025-03-04 CN disclosed
CN-119431164-A Process for preparing 2-amino-1- (4-isopropoxy-2-methylphenyl) -2-methylpropan-1-one 浙江工业大学 2025-02-14 CN disclosed
US-20250011297-A1 PROCESS AND INTERMEDIATES FOR PREPARATION OF ISOFETAMID ADAMA MAKHTESHIM LTD. (IL) 2025-01-09 US disclosed
US-5086071-A Improved chemical stability and ppotent in vivo TORAY INDUSTRIES, INC. (JP) 1992-02-04 US disclosed
EP-0232776-B1 2,5,6,7-TETRANOR-4,8-INTER-M-PHENYLENE PGI2 DERIVATIVES TORAY INDUSTRIES, INC. (JP) 1990-10-24 EP disclosed
EP-0389162-A1 2,5,6,7-Tetranor-4,8-inter-m-phenylene PGI2 derivatives TORAY INDUSTRIES, INC. (JP) 1990-09-26 EP disclosed
EP-0365678-A1 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLENE PGI 2 DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND USE THEREOF TORAY INDUSTRIES, INC. (JP) 1990-05-02 EP disclosed
US-4775692-A ANTILIPEMIC, ANTICOAGULANT, HYPOTENSIVE, ANTISECRETORY AND ANTIULCER AGENT TORAY INDUSTRIES, INC. (JP) 1988-10-04 US disclosed
EP-0232776-A2 2,5,6,7-tetranor-4,8-inter-m-phenylene PGI2 derivatives TORAY INDUSTRIES, INC. (JP) 1987-08-19 EP disclosed
JP-S6212732-A SYNTHESIS OF 3-ISOPROPYL-5-METHYLPHENOL HOKKO CHEM IND CO LTD 1987-01-21 JP disclosed
JP-S60139636-A PROCESS FOR PRODUCING THYMOL KANSAI COKE & CHEM CO LTD 1985-07-24 JP disclosed
US-3992455-A CHEMICAL INTERMEDIATES FOR INSECTICIDES KOPPERS COMPANY, INC. (US) 1976-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250011297-A1 PROCESS AND INTERMEDIATES FOR PREPARATION OF ISOFETAMID IDH2, FH, SDHA LMNA 4129/4885ACHE 646/4885RXRA 4481/4885
US-20250250370-A1 METHACRYLATE-CONTAINING COMPOSITION, METHOD FOR PRODUCING METHACRYLIC ESTER, POLYMERIZABLE COMPOSITION, AND METHOD FOR PRODUCING METHACRYLIC ACID POLYMER MMAB, MAT2B, MEP1B LMNA 1341/4885ACHE 2152/4885RXRA 1066/4885
US-20250250223-A1 ESTER COMPOUND-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, (METH)ACRYLIC POLYMER, AND METHOD FOR PRODUCING SAME MMAB, ADCY8, MAT1A LMNA 2398/4885ACHE 1106/4885RXRA 892/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.